From: Modeling patient access to therapeutic oxytocin in Zanzibar, Tanzania
Variable Name | Type | Description |
---|---|---|
Inflow of Drugs – Supply Chain from manufacturer to end-user | ||
Size of Shipment | DV | Weight or freight size of the shipment |
Frequency of Shipment | DV | Number of times a shipment occurs within a given period of time |
Baseline Cost Prior of Oxytocin Dose | DV | Aggregate cost of standard oxytocin dose |
Availability at Facility - Review of depreciation in drug quality | ||
Quality Depreciation due to Environment (ambient temperature) | DV | Extent of loss in drug quality due to ambient temperature conditions |
Natural Rate of Quality Decay | IV | Half-life of drug |
Accessibility - Patient Access – describes the patient’s access to health facilities. | ||
Travel time to health facility | IV | Distance to health center that suits patient’s needs |
Literacy | IV | School completion by patient or caregiver |
Wealth Quintile | DV | Patient’s access to funds |
Patient Access to Health Facility | DV | Fraction of percent of patients able to access adequate health facilities from those who need it. |